BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS




Industry
Biotechnology






 Company News
Eagle Pharmaceuticals (EGRX) Announces That Teva Pharmaceutical Industries Limited (TEVA) Requests A Motion To Dismiss With Prejudice In Its Bendamustine Patent Infringement Lawsuit 9/17/2014 10:45:19 AM
Teva Pharmaceutical Industries Limited (TEVA) Presents New Data Which Demonstrate Reduction Of Injection-Related Adverse Events With The Less Frequent Dosing Of Three-Times-A-Week COPAXONE® (Glatiramer Acetate Injection) 40 Mg Compared To Daily COPAXONE® 20 Mg 9/11/2014 7:59:33 AM
Teva Pharmaceutical Industries Limited (TEVA) CFO: No New Plans For Major Cuts 9/9/2014 6:40:12 AM
AbbVie (ABBV), Teva Pharmaceutical Industries Limited (TEVA) Illegally Blocked Generic Version Of AndroGel: Federal Trade Commission 9/9/2014 5:50:47 AM
Successful Completion Of Phase 3 Program For Teva Pharmaceutical Industries Limited (TEVA)’s Reslizumab Two More Phase Iii Studies Support The Benefits Of Reslizumab Treatment In Asthma Patients With Eosinophilia 9/8/2014 10:53:24 AM
Teva Pharmaceutical Industries Limited (TEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014 11:06:09 AM
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014 10:56:53 AM
Data To Be Presented At MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva Pharmaceutical Industries Limited (TEVA)’s Commitment To Developing Solutions To Meet The Needs Of The Multiple Sclerosis Community 9/3/2014 10:16:49 AM
Teva Pharmaceutical Industries Limited (TEVA) Launches SYNCare™ Home Administration Support Program For Patients On SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 9/3/2014 9:06:22 AM
UK Court Backs Teva Pharmaceutical Industries Limited (TEVA) Rival To AstraZeneca PLC (AZN) Lung Drug Symbicort 9/3/2014 5:56:05 AM
12345678910...